Alkermes plc. 8-K

What Happened Alkermes plc announced on January 12, 2026 that it made a corporate presentation available for its J.P. Morgan Healthcare Conference presentation on January 13, 2026. The presentation includes the company’s estimated total revenues for the year ended December 31, 2025. Alkermes notes these figures are preliminary, unaudited and subject to change pending completion of its year‑end financial review. The presentation is furnished as Exhibit 99.1 to the Form 8‑K.

Key Details

• Date filed: January 12, 2026; conference presentation scheduled for January 13, 2026.
• Content: Includes Alkermes’ estimated total revenues for year ended December 31, 2025 (no dollar amount disclosed in the 8‑K).
• Status: Estimates are preliminary and unaudited — subject to change upon completion of the company’s financial statement review.
• Regulatory note: The presentation and related information were furnished under Regulation FD and are not being treated as “filed” for certain Exchange Act purposes per Item 7.01.

Why It Matters A company-provided preliminary revenue estimate gives investors an early view into Alkermes’ 2025 top-line performance ahead of audited results and official filings (e.g., Form 10‑K). Because the figures are unaudited and may change, investors should treat this as guidance rather than final earnings results and watch for the company’s completed financial statements and any management commentary from the conference for confirmation.